NYSE:ANRO

Alto Neuroscience Stock Insider Trading

Healthcare > Biotechnology

Buy ANRO

*Your capital is at risk

$18.85

+0.140 (+0.748%)

At Close: Jun 03, 2026

Alto Neuroscience Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -26.05. In total, the insiders bought 5.35M and sold 4.02M ANRO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-26.05
● Buy	5.35M shares
● Sell	4.02M shares
67% Buy Activity Moderate Negative Correlation
Sell Signal Medium Confidence May 14, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -26.05. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Hanley Jr. Michael Conick Chief Operating Officer	C-Suite Officer	125 000 Value: $293.8K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Hanley Jr. Michael Conick Chief Operating Officer	C-Suite Officer	8 000 Value: $18.8K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Hanley Jr. Michael Conick Chief Operating Officer	C-Suite Officer	188 000 Value: $2.33M
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Hanley Jr. Michael Conick Chief Operating Officer	C-Suite Officer	125 000 Value: $525.0K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Hanley Jr. Michael Conick Chief Operating Officer	C-Suite Officer	8 000 Value: $119.0K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Savitz Adam Chief Medical Officer	Officer	123 645 Value: $290.6K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Savitz Adam Chief Medical Officer	Officer	76 000 Value: $178.6K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Savitz Adam Chief Medical Officer	Officer	73 000 Value: $171.6K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Savitz Adam Chief Medical Officer	Officer	33 008 Value: $77.6K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Savitz Adam Chief Medical Officer	Officer	22 481 Value: $52.8K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Savitz Adam Chief Medical Officer	Officer	76 000 Value: $319.2K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Savitz Adam Chief Medical Officer	Officer	33 008 Value: $205.6K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Savitz Adam Chief Medical Officer	Officer	123 645 Value: $655.3K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Savitz Adam Chief Medical Officer	Officer	73 000 Value: $1.09M
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Etkin Amit President And CEO	CEO / President	247 290 Value: $581.1K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Etkin Amit President And CEO	CEO / President	223 000 Value: $524.1K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Etkin Amit President And CEO	CEO / President	215 000 Value: $505.3K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Etkin Amit President And CEO	CEO / President	34 620 Value: $81.4K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Etkin Amit President And CEO	CEO / President	247 290 Value: $1.31M
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Etkin Amit President And CEO	CEO / President	223 000 Value: $3.32M
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Etkin Amit President And CEO	CEO / President	34 620 Value: $215.7K
Jul 03, 2025 Sell	Employee Stock Option (Right to Buy) D-Return	Etkin Amit President And CEO	CEO / President	215 000 Value: $903.0K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Smith Nicholas Conrad Chief Financial Officer & Cbo	C-Suite Officer	202 329 Value: $475.5K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Smith Nicholas Conrad Chief Financial Officer & Cbo	C-Suite Officer	135 000 Value: $317.3K
Jul 03, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Smith Nicholas Conrad Chief Financial Officer & Cbo	C-Suite Officer	90 000 Value: $211.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks